84 results
8-K
EX-99.1
AWH
Aspira Women`s Health Inc
6 Dec 04
Ciphergen Biosystems Closes Sale of BioSepra Process Chromatography Business to Pall Corporation
12:00am
optimization or to discover useful protein biomarkers that can act as novel drug targets or disease markers, the potential development … statements due to various factors, including the ProteinChip technology’s ability to validate and/or develop protein biomarkers as novel drug targets
8-K
EX-99.1
AWH
Aspira Women`s Health Inc
28 Oct 04
Entry into a Material Definitive Agreement
12:00am
purification optimization or to discover useful protein biomarkers that can act as novel drug targets or disease markers, the potential development … technology’s ability to speed up process optimization or validate and/or develop protein biomarkers as novel drug targets, diagnostic or toxicology
8-K
EX-99.1
AWH
Aspira Women`s Health Inc
12 May 03
Ciphergen Reports First Quarter 2003 Financial Results
12:00am
a powerful combination for generation of biological disease hypotheses and for identification of unique cellular targets and putative signaling pathways … protein biomarkers that may be useful as diagnostics, or even have therapeutic utility. Ciphergen and Biosite plan to analyze these biomarker targets
8-K
EX-99.1
AWH
Aspira Women`s Health Inc
18 Feb 05
Results of Operations and Financial Condition
12:00am
the elucidation of biological pathways perturbed by drug
treatment and even reveal new drug targets. As a separate
pharma …
response protein amplification cascade that may provide
targets for cancer detection, monitoring and therapeutics
8-K
EX-99.1
l916lcghhb5367
9 Aug 18
Vermillion Reports Second Quarter 2018 Financial Results
4:08pm
10-K405
zge40 wtejxmytrfj0
2 Apr 01
Annual report (delinquent filer disclosure)
12:00am
8-K
EX-99.1
ucuv2cb6d2slf7219gs
13 Aug 20
Aspira Women’s Health Reports Second Quarter 2020 Financial Results
4:38pm
PREC14A
h4jiqxcgc43j6
25 Apr 12
Preliminary proxy with contested solicitation
12:00am